These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34381508)

  • 1. Serotonin Syndrome in Children and Adolescents Exposed to Selective Serotonin Reuptake Inhibitors - A Review of Literature.
    Xuev S; Ickowicz A
    J Can Acad Child Adolesc Psychiatry; 2021 Aug; 30(3):156-164. PubMed ID: 34381508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
    Hosenbocus S; Chahal R
    J Can Acad Child Adolesc Psychiatry; 2011 Feb; 20(1):60-7. PubMed ID: 21286371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Monoamine Oxidase B Inhibitors and Selective Serotonin Reuptake Inhibitors.
    Aboukarr A; Giudice M
    Can J Hosp Pharm; 2018; 71(3):196-207. PubMed ID: 29955193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serotonin syndrome associated with linezolid use: a case report].
    Sahiner V; Erden Aki SO
    Turk Psikiyatri Derg; 2009; 20(4):398-402. PubMed ID: 20013432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSRI-Induced Indifference.
    Sansone RA; Sansone LA
    Psychiatry (Edgmont); 2010 Oct; 7(10):14-8. PubMed ID: 21103140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?
    Spies PE; Pot JLWH; Willems RPJ; Bos JM; Kramers C
    Eur J Hosp Pharm; 2017 Mar; 24(2):124-127. PubMed ID: 31156918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.
    Renoir T
    Front Pharmacol; 2013; 4():45. PubMed ID: 23596418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits.
    Molina KC; Fairman KA; Sclar DA
    Drug Healthc Patient Saf; 2018; 10():37-43. PubMed ID: 29760569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series.
    Masuka JT; Mchunu N; Mkhize Z; Thandar Y; Mosam A
    Australas J Dermatol; 2022 Feb; 63(1):e13-e20. PubMed ID: 34958129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis.
    Kotapati VP; Khan AM; Dar S; Begum G; Bachu R; Adnan M; Zubair A; Ahmed RA
    Front Psychiatry; 2019; 10():523. PubMed ID: 31447707
    [No Abstract]   [Full Text] [Related]  

  • 13. High risk and low prevalence diseases: Serotonin syndrome.
    Spadaro A; Scott KR; Koyfman A; Long B
    Am J Emerg Med; 2022 Nov; 61():90-97. PubMed ID: 36057215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.
    Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
    Front Oncol; 2012; 2():177. PubMed ID: 23227451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.
    Chow TW; Pollock BG; Milgram NW
    Neuropsychiatr Dis Treat; 2007; 3(5):627-36. PubMed ID: 19300592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
    Thom RP; Palumbo ML; Thompson C; McDougle CJ; Ravichandran CT
    Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Japanese version of the serotonin syndrome scale (JSSS)].
    Kaneda Y; Ohmori T; Hegerl U
    No To Shinkei; 2000 Jun; 52(6):507-10. PubMed ID: 10875122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review.
    Edinoff AN; Akuly HA; Hanna TA; Ochoa CO; Patti SJ; Ghaffar YA; Kaye AD; Viswanath O; Urits I; Boyer AG; Cornett EM; Kaye AM
    Neurol Int; 2021 Aug; 13(3):387-401. PubMed ID: 34449705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report.
    Meng Y; Yuen J
    J Pharm Pract; 2023 Jun; 36(3):705-710. PubMed ID: 34962845
    [No Abstract]   [Full Text] [Related]  

  • 20. Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm.
    Kelly JM; Rubenfeld GD; Masson N; Min A; Adhikari NKJ
    Crit Care Med; 2017 Jun; 45(6):e607-e616. PubMed ID: 28338497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.